These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 862312)

  • 1. Interruption of the enterohepatic circulation of phenprocoumon by cholestyramine.
    Meinertz T; Gilfrich HJ; Groth U; Jonen HG; Jähnchen E
    Clin Pharmacol Ther; 1977 Jun; 21(6):731-5. PubMed ID: 862312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cholestyramine interrupts the enterohepatic circulation of phenprocoumon: a new therapeutic possibility in the treatment of phenprocoumon overdose].
    Meinertz T; Jähnchen E; Gilfrich HJ; Groth U; Jonen HG
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1582-4. PubMed ID: 347787
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of induction and inhibition of drug metabolism on pharmacokinetics and anticoagulant activity of the enantiomers of phenprocoumon in rats.
    Schmidt W; Trenk D; Jähnchen E
    Pharmacology; 1980; 21(5):313-22. PubMed ID: 7433511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced elimination of warfarin during treatment with cholestyramine.
    Jähnchen E; Meinertz T; Gilfrich HJ; Kersting F; Groth U
    Br J Clin Pharmacol; 1978 May; 5(5):437-40. PubMed ID: 656283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of liver cirrhosis on the pharmacokinetics of phenprocoumon.
    Kitteringham NR; Büstgens L; Brundert E; Mineshita S; Ohnhaus EE
    Eur J Clin Pharmacol; 1984; 26(1):65-70. PubMed ID: 6714293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of flunixin in the cat: enterohepatic circulation and active transport mechanism in the liver.
    Horii Y; Ikenaga M; Shimoda M; Kokue E
    J Vet Pharmacol Ther; 2004 Apr; 27(2):65-9. PubMed ID: 15096102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the interruption of enterohepatic circulation of bile acids by cholestyramine on apolipoprotein gene expression in the rat.
    Felgines C; Mazur A; Rayssiguier Y
    Life Sci; 1994; 55(13):1053-60. PubMed ID: 8084210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man.
    Caldwell JH; Bush CA; Greenberger NJ
    J Clin Invest; 1971 Dec; 50(12):2638-44. PubMed ID: 5129315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective drug distribution and anticoagulant potency of the enantiomers of phenprocoumon in rats.
    Schmidt W; Jähnchen E
    J Pharm Pharmacol; 1977 May; 29(5):266-71. PubMed ID: 17688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between phenprocoumon and phytomenadion: a pharmacokinetic investigation in healthy volunteers.
    Haustein KO
    Biomed Biochim Acta; 1984; 43(12):1417-24. PubMed ID: 6534380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent metabolism and hepatic distribution of phenprocoumon in rats.
    Trenk D; Winkelmann B; Jähnchen E; Oie S
    J Pharmacokinet Biopharm; 1988 Feb; 16(1):1-12. PubMed ID: 3373415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Observations in phenprocoumon (Marcumar) poisoning. Elimination and serum binding of the anticoagulant atatoxic blood concentration].
    Held H; von Busse G; Meissner J
    Dtsch Med Wochenschr; 1980 Jun; 105(24):860-3. PubMed ID: 7418621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of phenprocoumon intoxication with cholestyramine.
    Meinertz T; Gilfrich MJ; Bork R; Jahnchen E
    Br Med J; 1977 Aug; 2(6084):439. PubMed ID: 890329
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans.
    Heimark LD; Toon S; Gibaldi M; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1987 Sep; 42(3):312-9. PubMed ID: 3621786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nabumetone. Evidence for the lack of enterohepatic circulation of the active metabolite 6-MNA in humans.
    Brett MA; Buscher G; Ellrich E; Greb WH; Kurth HJ; Rülander G; Schmerenbeck B; Haddock RE; Thawley AR
    Drugs; 1990; 40 Suppl 5():67-70. PubMed ID: 2081498
    [No Abstract]   [Full Text] [Related]  

  • 16. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication.
    Caldwell JH; Greenberger NJ
    J Clin Invest; 1971 Dec; 50(12):2626-37. PubMed ID: 5129314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of wheat bran on the pharmacokinetics of phenprocoumon in normal volunteers.
    Kitteringham NR; Mineshita S; Ohnhaus EE
    Klin Wochenschr; 1985 Jun; 63(12):537-9. PubMed ID: 2993733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of lorazepam in human beings: enterohepatic recirculation and first-pass effect.
    Herman RJ; Van Pham JD; Szakacs CB
    Clin Pharmacol Ther; 1989 Jul; 46(1):18-25. PubMed ID: 2743706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action. A drug interaction study.
    Ohnhaus EE; Berger W; Duckert F; Oesch F
    Klin Wochenschr; 1983 Sep; 61(17):851-8. PubMed ID: 6632727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of diazepam (valium) on the effect of phenprocoumon (marcumar) (author's transl)].
    Schunter C; Held H; Schmülling R
    Klin Wochenschr; 1978 Mar; 56(6):305-7. PubMed ID: 642402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.